Ethamsylate reduces immunoreactive prostacyclin metabolite in low birthweight infants with respiratory distress syndrome
- 1 December 1986
- journal article
- research article
- Published by Elsevier in Early Human Development
- Vol. 14 (3-4) , 239-244
- https://doi.org/10.1016/0378-3782(86)90185-4
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Micromethod for bleeding time in the newborn.Archives of Disease in Childhood, 1985
- Ultrasound and necropsy study of periventricular haemorrhage in preterm infants.Archives of Disease in Childhood, 1984
- Protective effect of vitamin E (DL-alpha-tocopherol) against intraventricular haemorrhage in premature babies.BMJ, 1983
- Developmental and neurological progress of preterm infants with intraventricular haemorrhage and ventricular dilatation.Archives of Disease in Childhood, 1982
- Timing of neonatal cerebroventricular haemorrhage with ultrasound.Archives of Disease in Childhood, 1982
- ETHAMSYLATE REDUCES THE INCIDENCE OF PERIVENTRICULAR HAEMORRHAGE IN VERY LOW BIRTH-WEIGHT BABIESThe Lancet, 1981
- PREVENTION OF INTRAVENTRICULAR HAEMORRHAGE IN PRETERM INFANTS BY PHENOBARBITONEThe Lancet, 1981
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- A DOUBLE-BLIND TRIAL OF ETHAMSYLATE IN THE TREATMENT OF PRIMARY AND INTRAUTERINE-DEVICE MENORRHAGIAThe Lancet, 1976
- THE RELEASE OF PROSTAGLANDINS FROM LUNG AND OTHER TISSUESAnnals of the New York Academy of Sciences, 1971